Citations

Clear

1526 citation(s) found for "Sun, Bo".

Obesity-metabolic derangement exacerbates cardiomyocyte loss distal to moderate coronary artery stenosis in pigs without affecting global cardiac function
Li, Zi-Lun, Ebrahimi, Behzad , Zhang, Xin , Eirin, Alfonso , Woollard, John R. , Wang, Shen-Ming, Lerman, Lilach O. , Tang, Hui Jun , Lerman, Amir , Eirin, Alfonso

Mayo Clinic

American Journal of Physiology-Heart and Circulatory Physiology | February 8, 2014 | Volume: 306 | Issue: 7 | Pages: H1087-H1101

10.1152/ajpheart.00052.2013 | PMID 24508639 Get It

Obesity associated with metabolic derangements (ObM) worsens the prognosis of patients with coronary artery stenosis (CAS), but the underlying cardiac pathophysiologic mechanisms remain elusive. We tested the hypothesis that ObM exacerbates cardiomyocyte loss distal to moderate CAS. Obesity-prone pigs were randomized to four groups ( n = 6 each): lean-sham, ObM-sham, lean-CAS, and ObM-CAS. Lean and ObM pigs were maintained on a 12-wk standard or atherogenic diet, respectively, and left circumflex CAS was then induced by placing local-irritant coils. Cardiac structure, function, and myocardial oxygenation were assessed 4 wk later by computed-tomography and blood oxygenation level dependent (BOLD) MRI, the microcirculation with micro-computed-tomography, and injury mechanisms by immunoblotting and histology. ObM pigs showed obesity, dyslipidemia, and insulin resistance. The degree of CAS (range, 50–70%) was similar in lean and ObM pigs, and resting myocardial perfusion and global cardiac function remained unchanged. Increased angiogenesis distal to the moderate CAS observed in lean was attenuated in ObM pigs, which also showed microvascular dysfunction and increased inflammation (M1-macrophages, TNF-α expression), oxidative stress (gp91), hypoxia (BOLD-MRI), and fibrosis (Sirius-red and trichrome). Furthermore, lean-CAS showed increased myocardial autophagy, which was blunted in ObM pigs (downregulated expression of unc-51-like kinase-1 and autophagy-related gene-12; P < 0.05 vs. lean CAS) and associated with marked apoptosis. The interaction diet xstenosis synergistically inhibited angiogenic, autophagic, and fibrogenic activities. ObM exacerbates structural and functional myocardial injury distal to moderate CAS with preserved myocardial perfusion, possibly due to impaired cardiomyocyte turnover.
Mitochondrial Dysfunction of Immortalized Human Adipose Tissue-Derived Mesenchymal Stromal Cells from Patients with Parkinson’s Disease
Moon, Hyo Eun , Yoon, Seung Hee, Hur, Yong Suk , Shim, Jung Hee, Yoo, Seung Hyun , Son, Jin H. , Paek, Seung Leal, Kim, In Kyeong , Hwang, Jae Ha , Jeon, Beom Seok , Paek, Sun Ha , Park, Sung Sup , Park, Hyung Woo , Ha, Ji Young , Kim, Kyung‐Hee , Kim, Han‐Joon

Mayo Clinic

Experimental Neurobiology | January 18, 2014 | Volume: 22 | Issue: 4 | Pages: 283-300

10.5607/en.2013.22.4.283 | PMID 24465144 Get It

Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK
Liu, Xiaona , Chhipa, Rishi Raj , Pooya, Shabnam, Wortman, Matthew D. , Yachyshin, Sara, Chow, Lionel M.L. , Zhou, Xuan , McPherson, Christopher, Warnick, Ronald E. , Kendler, Ady , Poels, Jeroen, Norga, Koen , Viollet, Benoı̂t , Grabowski, Gregory A. , Dasgupta, Biplab , Kumar, Ashish , Sun, Ying Hao , Quinn, Brian , Giri, Shailendra , Viollet, Benoit

Mayo Clinic

Proceedings of the National Academy of Sciences | January 13, 2014 | Volume: 111 | Issue: 4 | Pages: No page available

10.1073/pnas.1311121111 | PMID 24474794 Get It

Significance Cancer cells reprogram their metabolism for optimal growth and survival. AMPK-activated protein kinase (AMPK) is a key energy sensor that controls many metabolic pathways including metabolic reprogramming. However, its role in cancer is poorly understood. Some studies claim that it has a tumor suppressor role while others show its protumor role. Two AMPK-activating compounds (including metformin, now in many clinical trials) are widely used to suppress cancer cell proliferation. We found that AMPK is abundantly expressed in high-grade gliomas and, in contrast to popular belief, these two AMPK activators suppressed glioma cell proliferation through unique AMPK-independent mechanisms.
High Expression of Somatostatin Receptors and Messenger Ribonucleic Acid for Its Receptor Subtypes in Organ-Confined and Locally Advanced Human Prostate Cancers1
Halmos, Gábor, Davis, Rodney , Bostwick, David G., Płonowski, Artur , Schally, Andrew V. , Sun, Baodong

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | January 8, 2014 | Volume: 85 | Issue: 7 | Pages: 2564-2571

10.1210/jcem.85.7.6698 | PMID 10902809 Get It

To evaluate the potential application of somatostatin (SST) analogs as an adjuvant treatment for prostate cancer, we characterized the binding sites for SST octapeptide analogs on prostate cancers in patients treated with radical prostatectomy. The affinity and density of binding sites for SST analog RC-160 on 80 surgical specimens of prostate cancers were determined by ligand competition assays. The expression of messenger ribonucleic acid (mRNA) for SST receptor subtype 1 (SSTR1), subtype 2 (SSTR2), and subtype 5 (SSTR5) was also investigated in 22 samples by RT-PCR. Fifty-two of 80 specimens (65%), showed a single class of specific binding sites for RC-160 with a mean dissociation constant (Kd) of 9.44 nmol/L and a mean maximal binding capacity of 754.8 fmol/mg membrane protein. The mRNA for SSTR1 was detected in 86% of samples, whereas the incidences of mRNA for SSTR2 and SSTR5 were 14% and 64%, respectively. The expression of SSTR2 and/or SSTR5 was 100%, consistent with the presence of RC-160 binding. In patients at high risk of cancer recurrence (stage pT3 and/or Gleason score of 8–10), the incidence of RC-160 binding (65.7%) was similar to that observed in the low risk group (64.3%). The demonstration of the high incidence of octapeptide-preferring SSTRs in organ-confined and locally advanced prostate cancers supports the merit of further investigations of the application of SST analogs and their radionuclide and cytotoxic derivatives for adjuvant treatment of patients at high risk of cancer recurrence after radical prostatectomy. Such approaches could be also considered for patients with advanced prostate cancer at the time of relapse.
CrossMap: a versatile tool for coordinate conversion between genome assemblies
Zhao, Hao , Sun, Zhifu , Kocher, Jean‐Pierre , Wang, Liguo , Wang, Jing , Huang, Haojie , Sun, Zhifu , Wang, Liguo

Mayo Clinic

Bioinformatics | December 19, 2013 | Volume: 30 | Issue: 7 | Pages: 1006-1007

10.1093/bioinformatics/btt730 | PMID 24351709 Get It

Abstract Motivation: Reference genome assemblies are subject to change and refinement from time to time. Generally, researchers need to convert the results that have been analyzed according to old assemblies to newer versions, or vice versa, to facilitate meta-analysis, direct comparison, data integration and visualization. Several useful conversion tools can convert genome interval files in browser extensible data or general feature format, but none have the functionality to convert files in sequence alignment map or BigWig format. This is a significant gap in computational genomics tools, as these formats are the ones most widely used for representing high-throughput sequencing data, such as RNA-seq, chromatin immunoprecipitation sequencing, DNA-seq, etc. Results: Here we developed CrossMap, a versatile and efficient tool for converting genome coordinates between assemblies. CrossMap supports most of the commonly used file formats, including BAM, sequence alignment map, Wiggle, BigWig, browser extensible data, general feature format, gene transfer format and variant call format. Availability and implementation: CrossMap is written in Python and C. Source code and a comprehensive user’s manual are freely available at: http://crossmap.sourceforge.net/. Contact: Kocher.JeanPierre@mayo.edu or wang.liguo@mayo.edu Supplementary information: Supplementary data are available at Bioinformatics online.
Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation Timing and Modality
Fenske, Timothy S. , Zhang, Mei-Jie , Carreras, Jeanette, Ayala, Ernesto , Burns, Linda J. , Cashen, Amanda F. , Costa, Luciano J. , Freytes, César O. , Holmberg, Leona , Inwards, David J. , Munker, Reinhold , Rizzieri, David A. , Schouten, Harry C. , Smith, Sonali M. , Waller, Edmund K. , Wirk, Baldeep , Laport, Ginna G. , Maloney, David G. , Montoto, Silvia , Hari, Parameswaran , Holmberg, Leona , Zhang, Mei‐Jie , Gale, Robert Peter , Hamadani, Mehdi , Lazarus, Hillard M. , Maziarz, Richard Thomas , Perales, Miguel‐Angel , Waller, Edmund K , Montoto, Silvia , Costa, Luciano J , Hari, Parameswaran

Mayo Clinic

Journal of Clinical Oncology | December 17, 2013 | Volume: 32 | Issue: 4 | Pages: 273-281

10.1200/jco.2013.49.2454 | PMID 24344210 Get It

PurposeTo examine the outcomes of patients with chemotherapy-sensitive mantle-cell lymphoma (MCL) following a first hematopoietic stem-cell transplantation (HCT), comparing outcomes with autologous (auto) versus reduced-intensity conditioning allogeneic (RIC allo) HCT and with transplantation applied at different times in the disease course.Patients and MethodsIn all, 519 patients who received transplantations between 1996 and 2007 and were reported to the Center for International Blood and Marrow Transplant Research were analyzed. The early transplantation cohort was defined as those patients in first partial or complete remission with no more than two lines of chemotherapy. The late transplantation cohort was defined as all the remaining patients.ResultsAuto-HCT and RIC allo-HCT resulted in similar overall survival from transplantation for both the early (at 5 years: 61% auto-HCT v 62% RIC allo-HCT; P = .951) and late cohorts (at 5 years: 44% auto-HCT v 31% RIC allo-HCT; P = .202). In both early and late transplantation cohorts, progression/relapse was lower and nonrelapse mortality was higher in the allo-HCT group. Overall survival and progression-free survival were highest in patients who underwent auto-HCT in first complete response. Multivariate analysis of survival from diagnosis identified a survival benefit favoring early HCT for both auto-HCT and RIC allo-HCT.ConclusionFor patients with chemotherapy-sensitive MCL, the optimal timing for HCT is early in the disease course. Outcomes are particularly favorable for patients undergoing auto-HCT in first complete remission. For those unable to achieve complete remission after two lines of chemotherapy or those with relapsed disease, either auto-HCT or RIC allo-HCT may be effective, although the chance for long-term remission and survival is lower.
Efficient B Cell Responses to Borrelia hermsii Infection Depend on BAFF and BAFFR but Not TACI
Dickinson, Gregory S., Sun, Guizhi, Bram, Richard J. , Alugupalli, Kishore R.

Mayo Clinic

Infection and Immunity | November 12, 2013 | Volume: 82 | Issue: 1 | Pages: 453-459

10.1128/iai.01147-13 | PMID 24218480 Get It

ABSTRACT T cell-independent antibody responses develop rapidly, within 3 to 4 days, and are critical for preventing blood-borne pathogens from evolving into life-threatening infections. The interaction of BAFF, also known as BLyS, with its receptors BAFFR and TACI on B cells is critical for B cell homeostasis and function. Using a synthetic polysaccharide antigen, it has previously been shown that TACI is critical for T cell-independent antibody responses. To examine the role of BAFFR and TACI in T cell-independent antibody responses to an active infection, we utilized the Borrelia hermsii infection system. In this infection system, T cell-independent responses mediated by the B1b cell subset are critical for controlling bacteremia. We found that B1b cells express BAFFR and TACI and that the surface expression of both receptors is upregulated on B1b cells following exposure to whole B. hermsii cells. Surprisingly, we found that TACI −/− mice are not impaired either in specific antibody responses to B. hermsii or in controlling B. hermsii bacteremia. In contrast, TACI-deficient mice immunized with heat-killed type 3 serotype pneumococcus cells are impaired in generating pneumococcal polysaccharide-specific responses and succumb to challenge with live type 3 serotype pneumococcus, indicating that TACI is required for T cell-independent antibody responses to bacterial-associated polysaccharides. Although we have found that TACI is dispensable for controlling B. hermsii infection, mice deficient in BAFFR or BAFF exhibit impairment in B. hermsii -specific IgM responses and clearance of bacteremia. Collectively, these data indicate a disparity in the roles for TACI and BAFFR in primary T cell-independent antibody responses to bacterial pathogens.
P2–144: Age‐related frontal lobe compensation during novelty detection
Shi, Jiong , Sabbagh, Marwan, Caselli, Richard J. , Chong, Catherine D. , Chen, Kewei , Baxter, Leslie C.

Mayo Clinic

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_10 | Pages: No page available

10.1016/j.jalz.2013.05.788 Get It

IC‐P‐032: Effect of measurement variability on hippocampal volume‐based clinical trial enrichment
Yu, Peng , Wolz, Robin, Stephenson, Diane , Cole, Patricia E., Hill, David , Schwarz, Adam J. , Ji, Sun , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_1 | Pages: No page available

10.1016/j.jalz.2013.05.033 Get It